ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,793Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 403

$772K Total Retail Price of All Prescriptions

Rank: 13 out of 403

471 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 8,707 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 398 369 1 7
LEVOTHYROXINE SODIUM 331 298 2 3
SIMVASTATIN 318 279 3 2
WARFARIN SODIUM 278 211 4 12
AMLODIPINE BESYLATE 259 245 5 4
LISINOPRIL 235 214 6 1
ATORVASTATIN CALCIUM 234 204 7 5
METOPROLOL TARTRATE 213 195 8 10
OMEPRAZOLE 183 128 9 9
METFORMIN HCL 167 153 10 8
OXYCODONE HCL 163 70 S2 11 39
HYDROCODONE-ACETAMINOPHEN 152 107 S3 12 15
DIOVAN 144 128 13 24
OXYCODONE-ACETAMINOPHEN 139 62 S2 14 45
GLIMEPIRIDE 135 116 15 61
SPIRONOLACTONE 129 101 16 100
SERTRALINE HCL 128 123 17 20
MIRTAZAPINE 123 112 18 38
CITALOPRAM HBR 123 106 18 22
ATENOLOL 121 121 20 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 119 115 21 29
GABAPENTIN 118 90 22 17
PREDNISONE 103 79 23 34
FAMOTIDINE 103 103 23 73
JANUVIA 101 99 25 44
CRESTOR 97 78 26 19
MELOXICAM 93 85 27 58
PRAVASTATIN SODIUM 90 83 28 14
ALLOPURINOL 86 74 29 31
POTASSIUM CHLORIDE 80 73 30 37
FENOFIBRATE 79 67 31 132
CEFUROXIME 78 59 32 183
NAMENDA 78 78 32 41
CARVEDILOL 77 70 34 32
LANTUS 76 67 35 54
DIGOXIN 75 67 36 56
DONEPEZIL HCL 74 61 37 23
METOPROLOL SUCCINATE 74 64 37 11
TRAMADOL HCL 73 39 39 28
BUPROPION XL 67 30 40 159
SYNTHROID 66 63 41 51
ZOLPIDEM TARTRATE 66 50 41 16
LOSARTAN POTASSIUM 65 65 43 21
CLOPIDOGREL 65 60 43 55
BISOPROLOL-HYDROCHLOROTHIAZIDE 64 54 45 181
OXYCONTIN 62 21 S2 46 63
TAMSULOSIN HCL 62 43 46 27
LIPITOR 60 55 48 53
HYDROCHLOROTHIAZIDE 60 60 48 6
LIDODERM 57 57 50 74
ESCITALOPRAM OXALATE 56 28 51 36
TRAZODONE HCL 54 47 52 25
ACTOS 53 34 53 95
ZETIA 51 39 54 59
OXYCODONE HCL-ACETAMINOPHEN 51 27 S2 54 89
QUETIAPINE FUMARATE 51 37 54 52
NEXIUM 51 27 54 18
ADVAIR DISKUS 50 29 58 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.